Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Fox News

New option available for Alzheimer’s patients as FDA approves expanded drug use

New option available for Alzheimer’s patients as FDA approves expanded drug use
ShareXFacebook

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.

F

Source

Fox News

Read full article at Fox News

Opens original article in a new tab

Advertisement

Related General Stories

Advertisement